Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017 (2017), Article ID 2354564, 13 pages
https://doi.org/10.1155/2017/2354564
Research Article

Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures

Department of Biostatistics and Bioinformatics, Division of Population Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Correspondence should be addressed to Anders E. Berglund

Received 27 September 2016; Revised 15 December 2016; Accepted 4 January 2017; Published 6 February 2017

Academic Editor: Bethany Wolf

Copyright © 2017 Anders E. Berglund et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. T. Jolliffe, Principal Component Analysis, Springer, New York, NY, USA, 2nd edition, 2002.
  2. D. Venet, J. E. Dumont, and V. Detours, “Most random gene expression signatures are significantly associated with breast cancer outcome,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Simon, “Roadmap for developing and validating therapeutically relevant genomic classifiers,” Journal of Clinical Oncology, vol. 23, no. 29, pp. 7332–7341, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Simon, M. D. Radmacher, K. Dobbin, and L. M. McShane, “Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification,” Journal of the National Cancer Institute, vol. 95, no. 1, pp. 14–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Baek, C.-A. Tsai, and J. J. Chen, “Development of biomarker classifiers from high-dimensional data,” Briefings in Bioinformatics, vol. 10, no. 5, pp. 537–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Wang, D. J. Miller, and R. Clarke, “Approaches to working in high-dimensional data spaces: gene expression microarrays,” British Journal of Cancer, vol. 98, no. 6, pp. 1023–1028, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Michiels, S. Koscielny, and C. Hill, “Interpretation of microarray data in cancer,” British Journal of Cancer, vol. 96, no. 8, pp. 1155–1158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Castaldi, I. J. Dahabreh, and J. P. A. Ioannidis, “An empirical assessment of validation practices for molecular classifiers,” Briefings in Bioinformatics, vol. 12, no. 3, Article ID bbq073, pp. 189–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. Ransohoff, “Rules of evidence for cancer molecular-marker discovery and validation,” Nature Reviews Cancer, vol. 4, no. 4, pp. 309–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Royston and D. G. Altman, “External validation of a Cox prognostic model: principles and methods,” BMC Medical Research Methodology, vol. 13, no. 1, article 33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. G. Altman and P. Royston, “What do we mean by validating a prognostic model?” Statistics in Medicine, vol. 19, no. 4, pp. 453–473, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mallett, P. Royston, S. Dutton, R. Waters, and D. G. Altman, “Reporting methods in studies developing prognostic models in cancer: a review,” BMC Medicine, vol. 8, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Mallett, P. Royston, R. Waters, S. Dutton, and D. G. Altman, “Reporting performance of prognostic models in cancer: a review,” BMC Medicine, vol. 8, article 21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Chibon, “Cancer gene expression signatures—the rise and fall?” European Journal of Cancer, vol. 49, no. 8, pp. 2000–2009, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Weigelt, L. Pusztai, A. Ashworth, and J. S. Reis-Filho, “Challenges translating breast cancer gene signatures into the clinic,” Nature Reviews Clinical Oncology, vol. 9, no. 1, pp. 58–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Koscielny, “Why most gene expression signatures of tumors have not been useful in the clinic,” Science Translational Medicine, vol. 2, no. 14, p. 14ps2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Kern, “Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures,” Cancer Research, vol. 72, no. 23, pp. 6097–6101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Dupuy and R. M. Simon, “Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting,” Journal of the National Cancer Institute, vol. 99, no. 2, pp. 147–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Micheel, S. J. Nass, and G. S. Omenn, Evolution of Translational Omics: Lessons Learned and the Path Forward, National Academies Press, Washington, DC, USA, 2012. View at Publisher · View at Google Scholar
  20. R. Bro and A. K. Smilde, “Principal component analysis,” Analytical Methods, vol. 6, no. 9, pp. 2812–2831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Michiels, S. Koscielny, and C. Hill, “Prediction of cancer outcome with microarrays: a multiple random validation strategy,” The Lancet, vol. 365, no. 9458, pp. 488–492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Haibe-Kains, C. Desmedt, C. Sotiriou, and G. Bontempi, “A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?” Bioinformatics, vol. 24, no. 19, pp. 2200–2208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Shedden, J. M. G. Taylor, S. A. Enkemann et al., “Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study,” Nature Medicine, vol. 14, no. 8, pp. 822–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. E. Johnson, C. Li, and A. Rabinovic, “Adjusting batch effects in microarray expression data using empirical Bayes methods,” Biostatistics, vol. 8, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  25. E. A. Welsh, S. A. Eschrich, A. E. Berglund, and D. A. Fenstermacher, “Iterative rank-order normalization of gene expression microarray data,” BMC Bioinformatics, vol. 14, article no. 153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. R. Peres-Neto, D. A. Jackson, and K. M. Somers, “How many principal components? Stopping rules for determining the number of non-trivial axes revisited,” Computational Statistics & Data Analysis, vol. 49, no. 4, pp. 974–997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Jackson, “Stopping rules in principal components analysis: a comparison of heuristical and statistical approaches,” Ecology, vol. 74, no. 8, pp. 2204–2214, 1993. View at Google Scholar · View at Scopus
  28. M. H. W. Starmans, B. Krishnapuram, H. Steck et al., “Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types,” British Journal of Cancer, vol. 99, no. 11, pp. 1884–1890, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. Mosley and R. A. Keri, “Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists,” BMC Medical Genomics, vol. 1, article 11, 2008. View at Publisher · View at Google Scholar
  30. C. Brulard and F. Chibon, “Robust gene expression signature is not merely a significant P value,” European Journal of Cancer, vol. 49, no. 12, pp. 2771–2773, 2013. View at Publisher · View at Google Scholar · View at Scopus